MaxCyte, Inc. (LON:MXCT – Get Free Report) insider Stan Erck sold 47,689 shares of the firm’s stock in a transaction that occurred on Wednesday, October 2nd. The stock was sold at an average price of GBX 388 ($5.19), for a total value of £185,033.32 ($247,503.10).
MaxCyte Price Performance
Shares of MXCT stock opened at GBX 280 ($3.75) on Friday. The stock has a 50 day moving average of GBX 316.07 and a two-hundred day moving average of GBX 332.60. The company has a current ratio of 14.31, a quick ratio of 14.38 and a debt-to-equity ratio of 8.37. MaxCyte, Inc. has a 12 month low of GBX 180 ($2.41) and a 12 month high of GBX 430 ($5.75). The company has a market capitalization of £294.25 million, a P/E ratio of -1,120.00 and a beta of 1.13.
MaxCyte Company Profile
Featured Stories
- Five stocks we like better than MaxCyte
- What is the Nikkei 225 index?
- The Outlook for Interest Rate Cuts Got Blown Out of the Water
- How to Evaluate a Stock Before Buying
- 3 High-Risk, High-Reward Micro-Cap Stocks You Shouldn’t Ignore
- Procter & Gamble (NYSE:PG) Pulls Back After Shaky Guidance
- 3 Bargain Stocks Positioned for Gains After Missing 2024’s Rally
Receive News & Ratings for MaxCyte Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MaxCyte and related companies with MarketBeat.com's FREE daily email newsletter.